Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) traded down 3.9% on Friday . The company traded as low as $0.40 and last traded at $0.40. 4,999 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 5,573 shares. The stock had previously closed at $0.41.
Spectral Medical Trading Down 3.9 %
The company’s 50-day moving average is $0.37 and its two-hundred day moving average is $0.42. The stock has a market capitalization of $113.22 million, a P/E ratio of -5.69 and a beta of 0.87.
Spectral Medical (OTCMKTS:EDTXF – Get Free Report) last issued its quarterly earnings data on Friday, November 8th. The company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $0.37 million during the quarter.
Spectral Medical Company Profile
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Further Reading
- Five stocks we like better than Spectral Medical
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Stock Splits, Do They Really Impact Investors?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How Technical Indicators Can Help You Find Oversold Stocks
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
